We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Carotid Stenting Should Be Avoided in Older Patients

By HospiMedica International staff writers
Posted on 06 Oct 2010
A new study recommends that stenting for symptomatic carotid stenosis in patients 70 years and older should be avoided, although the procedure might be as safe as endarterectomy in younger patients.

Researchers at University College London (United Kingdom), University Hospital Basel (Switzerland), and other institutions conducted a prospectively defined meta-analysis of individual patient data from three randomized controlled trials: the Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial, the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) trial, and the International Carotid Stenting Study (ICSS).The data from the trials, comprising 3,433 patients, were pooled and analyzed, with any stroke or death as the primary outcome.

The researchers found that in the first 120 days after randomization, any stroke or death was 53% more likely to occur in the carotid stenting group, occurring in 8.9% of the patients randomly assigned to stenting, compared to 5.8% in patients randomly assigned to carotid endarterectomy. More...
Of all subgroup variables assessed in the meta-analysis, only age significantly modified the treatment effect. While in patients younger than 70 years, the estimated 120-day risk for stroke or death was 5.8% in the carotid stenting group and 5.7% in the carotid endarterectomy group, in patients 70 years or older, the estimated risk for stroke or death was twice that with carotid endarterectomy: 12.0% versus 5.9%. The findings also suggest that stenting might be a viable alternative to endarterectomy in younger patients, although there is some uncertainty about the potentially higher rate of recurrent stenosis after stenting, and the implications this might have for future stroke risk in these patients. The study was published early online on September 10, 2010, in the Lancet.

"There is strong evidence that, in the short term, the harm of stenting compared with endarterectomy decreases with younger age,” concluded lead author Martin Brown, M.D., and colleagues of the carotid stenting trialists' collaboration. "An approach of offering stenting when technically feasible as an alternative option to endarterectomy to patients younger than 65-70 years with symptomatic carotid stenosis, in centers in which acceptable periprocedural outcomes have been independently verified, might seem justified, as long as patients are made aware of a possible increase in the risk of restenosis.”

Related Links:

University College London
University Hospital Basel


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.